Pharmaceutical Co-crystals: A Systematic Review

被引:6
|
作者
Jayram, Puneeth [1 ]
Sudheer, Preethi [1 ]
机构
[1] Krupanidhi Coll Pharm, Dept Pharmaceut, Bangalore 560035, Karnataka, India
关键词
Solubility; Nano cocrystals; Coformers; Characterization; Crystallisation; Bioavailability; ACID COCRYSTALS; SOLUBILITY; ENHANCEMENT; TECHNOLOGY; EZETIMIBE;
D O I
10.5330/ijpi.2020.3.45
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Low aqueous solubility and concomitant oral bioavailability are the major glitches found in converting the active pharmaceutical ingredients to new pharmaceutical products. Many methods are in existence to improve the solubility of poorly water-soluble drugs. Co-crystallization is one of the unique technique that aggregates two or more different chemical entities in a crystalline lattice via non-covalent bonding. Co-crystals are multi-component system of an active pharmaceutical ingredient and a conformer. They offer products with superior physico-chemical properties such as melting point, solubility, stability, bioavailability, compaction and permeability. This paper focuses on the utility of co crystals in promoting the solubility of the active pharmaceutical ingredient with special emphasis on the principle of co crystallization, methods of preparation and a survey on various cocrystal formulations and its application.
引用
收藏
页码:246 / 252
页数:7
相关论文
共 50 条
  • [1] Pharmaceutical co-crystals - a review
    Sekhon, B. S.
    ARS PHARMACEUTICA, 2009, 50 (03) : 99 - 117
  • [2] Polymorphism in Co-Crystals and Pharmaceutical Co-Crystals
    Zaworotko, Mike
    Peddy, Vishweshwar
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2005, 61 : C12 - C13
  • [3] Pharmaceutical Co-crystals with Isonicotinamide
    Bathori, Nikoletta B.
    Lemmerer, Andreas
    Venter, Gerhard A.
    Bourne, Susan A.
    Caira, Mino R.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2012, 68 : S220 - S220
  • [4] Altering physical properties of pharmaceutical co-crystals in a systematic manner
    Aakeroey, Christer B.
    Forbes, Safiyyah
    Desper, John
    CRYSTENGCOMM, 2014, 16 (26): : 5870 - 5877
  • [5] Crystal Engineering of Pharmaceutical Co-crystals: "NMR Crystallography" of Niclosamide Co-crystals
    Luedeker, David
    Gossmann, Rebecca
    Langer, Klaus
    Brunklaus, Gunther
    CRYSTAL GROWTH & DESIGN, 2016, 16 (06) : 3087 - 3100
  • [6] The role of co-crystals in pharmaceutical design
    Steed, Jonathan W.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2013, 34 (03) : 185 - 193
  • [7] Pharmaceutical co-crystals - are we there yet?
    Blagden, N.
    Colesb, S. J.
    Berry, D. J.
    CRYSTENGCOMM, 2014, 16 (26): : 5753 - 5761
  • [8] A Review about Regulatory Status and Recent Patents of Pharmaceutical Co-Crystals
    Kumar, Arun
    Kumar, Sandeep
    Nanda, Arun
    ADVANCED PHARMACEUTICAL BULLETIN, 2018, 8 (03) : 355 - 363
  • [9] Physicochemical properties of pharmaceutical co-crystals: A case study of ten AMG 517 co-crystals
    Stanton, Mary K.
    Bak, Annette
    CRYSTAL GROWTH & DESIGN, 2008, 8 (10) : 3856 - 3862
  • [10] Synthesis, characterization and properties of pharmaceutical co-crystals
    Hickey, Magali B.
    Peterson, Matthew L.
    Remenar, Julius F.
    Guzman, Hector R.
    Almarsson, Orn
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231